5 Biotechnological preparations for medical use for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations for medical purposes for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations, namely, nucleic recombinant acids for medical use